Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Rani Therapeutics Holdings
AddedMar 20, 2024
UpdatedJun 18, 2026
Rani Therapeutics Holdings

Rani Therapeutics Holdings

Public

Rani Therapeutics in San Jose develops innovative oral biologics for various medical conditions.

HQ
San Jose, CA, US
Overview
Compare
Employees
Website

Founded in San Jose, California, Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company focused on revolutionizing drug delivery through its innovative RaniPill capsule. The company's mission is to transform the administration of biologics by making them orally available, thus improving patient compliance and expanding therapeutic possibilities. Rani Therapeutics' product pipeline includes RT-101 for neuroendocrine tumors and acromegaly, and RT-102 for parathyroid hormone deficiencies.

Notable figures associated with Rani Therapeutics include its founder Mir Imran, a renowned medical device innovator. The company has attracted significant investment from leading venture capital firms and strategic partners. Key achievements include the successful completion of Phase I clinical trials for RT-101, demonstrating the potential of their oral delivery platform. Rani Therapeutics' work has the potential to significantly impact the biotherapeutics market by providing a more convenient and effective method of drug administration.

Rani Therapeutics Holdings - Similar Companies

Rise Therapeutics logo

Rise Therapeutics

Rapt Therapeutics logo

Rapt Therapeutics

rapt.com

Rnaderm Therapeutics logo

Rnaderm Therapeutics

i2o Therapeutics logo

i2o Therapeutics

i2obio.com

Rainier Therapeutics logo

Rainier Therapeutics

Denali Therapeutics logo

Denali Therapeutics

Orna Therapeutics logo

Orna Therapeutics

Pliant Therapeutics logo

Pliant Therapeutics

pliantrx.com

Mahzi Therapeutics logo

Mahzi Therapeutics

mahzi.com

ReviR Therapeutics logo

ReviR Therapeutics

revirtx.com

Intact Therapeutics logo

Intact Therapeutics

RS BioTherapeutics logo

RS BioTherapeutics

Entrada Therapeutics logo

Entrada Therapeutics

entradatx.com

Ryne Biotechnology logo

Ryne Biotechnology

Toralgen logo

Toralgen

toralgen.com

Rani Therapeutics Holdings - Quick Facts

Who are Rani Therapeutics Holdings' competitors?

Companies similar to Rani Therapeutics Holdings include Rise Therapeutics, Rapt Therapeutics, Rnaderm Therapeutics and i2o Therapeutics.

Where is Rani Therapeutics Holdings' headquarters located?

Rani Therapeutics Holdings' headquarters is located in San Jose, CA, US.

How many employees does Rani Therapeutics Holdings have?

Rani Therapeutics Holdings has 163 employees as of Feb 6, 2024.

Rani Therapeutics Holdings - Classification

Industry
  • Therapeutics
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biotherapeutics
  • Drugs
Tags
  • Healthtech
Unique IDs
  • ein: 000000000
  • secCik: 0001856725
  • ticker: RANI
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research